Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Clinical trial NCT00846456 · COMPLETED

Trial details

NCT number: NCT00846456
Sponsor: Oslo University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Brain Tumor

Start date: 2009-01-01
Primary completion: 2013-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.